Inactive Instrument

Tekla Healthcare Investors Share Price Nyse

Equities

US4040521027

Closed End Funds

End-of-day quote Nyse
- USD - Intraday chart for Tekla Healthcare Investors
Sales 2022 8.27M 690M Sales 2023 10.29M 859M Capitalization 752M 62.74B
Net income 2022 -194M -16.19B Net income 2023 56M 4.67B EV / Sales 2022 97.9 x
Net Debt 2022 8.49M 709M Net cash position 2023 214 17.86K EV / Sales 2023 73.1 x
P/E ratio 2022
-4.21 x
P/E ratio 2023
13.6 x
Employees -
Yield 2022
10.6%
Yield 2023
10.4%
Free-Float 95.5%
More Fundamentals * Assessed data
Abrdn Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2024 CI
Abrdn Healthcare Investors Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Tekla Healthcare Investors Insider Bought Shares Worth $148,515, According to a Recent SEC Filing MT
Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund and Tekla Healthcare Investors Approves Election of Rose Dimartino, C. William Maher, Todd Reit and Stephen Bird as New Trustees CI
Tekla Healthcare Investors Declares Distribution, Payable on September 29, 2023 CI
Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2023 CI
Tekla Healthcare Investors Declares Distribution, Payable Date Is June 30, 2023 CI
Tekla Healthcare Investors Declare Dividend, Payable on March 31, 2023 CI
Tekla Healthcare Investors Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Tekla Healthcare Investors Declares Distribution, Payable December 30, 2022 CI
Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2022 CI
Tekla Healthcare Investors Declares Distribution, Payable on June 30, 2022 CI
Tekla Healthcare Investors Renews Share Buyback Program MT
Tekla Healthcare Investors authorizes a Buyback Plan. CI
Tekla Healthcare Investors announces an Equity Buyback for 12% of its outstanding shares. CI
More news
Managers TitleAgeSince
President 71 01/01/01
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 74 01/07/01
President 71 01/01/01
Director/Board Member 62 01/20/01
More insiders
abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.
More about the company